DZ1926A1 - Formulations pharmaceutiques. - Google Patents

Formulations pharmaceutiques.

Info

Publication number: DZ1926A1
Authority: DZ; Algeria
Prior art keywords: pharmaceutical formulations; formulations; pharmaceutical
Prior art date: 1994-09-03

Application number

DZ950107A

Other languages

English (en)

Original Assignee

Smithkline Beckman P L C

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-09-03

Filing date

1995-08-02

Publication date

2002-02-17

1994-09-03 Priority claimed from GB9417953A external-priority patent/GB9417953D0/en

1995-02-24 Priority claimed from GBGB9503752.9A external-priority patent/GB9503752D0/en

1995-08-02 Application filed by Smithkline Beckman P L C filed Critical Smithkline Beckman P L C

2002-02-17 Application granted granted Critical

2002-02-17 Publication of DZ1926A1 publication Critical patent/DZ1926A1/fr

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

DZ950107A 1994-09-03 1995-08-02 Formulations pharmaceutiques. DZ1926A1 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB9417953A GB9417953D0 (en)	1994-09-03	1994-09-03	Pharmaceutical formulations
GBGB9503752.9A GB9503752D0 (en)	1995-02-24	1995-02-24	Pharmaceutical formulations
US46044195A	1995-06-02	1995-06-02

Publications (1)

Publication Number	Publication Date
DZ1926A1 true DZ1926A1 (fr)	2002-02-17

Family

ID=27267365

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ950107A DZ1926A1 (fr)	1994-09-03	1995-08-02	Formulations pharmaceutiques.

Country Status (8)

Country	Link
EP (1)	EP0782443A1 (fr)
JP (1)	JPH10505595A (fr)
AU (1)	AU3471995A (fr)
DZ (1)	DZ1926A1 (fr)
IL (1)	IL115125A0 (fr)
MA (1)	MA23663A1 (fr)
TR (1)	TR199501082A2 (fr)
WO (1)	WO1996007408A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT862431E (pt)	1995-09-07	2002-04-29	Smithkline Beecham Plc	Utilizacao de uma formulacao farmaceutica pediatrica que compreende amoxicilina e clavulanato
SK110299A3 (en) *	1997-02-14	2000-08-14	Smithkline Beecham Lab	Pharmaceutical formulations comprising amoxocyllin and clavulanate, preparation method and use thereof
US6706290B1 (en)	1998-07-06	2004-03-16	Olvai E. Kajander	Methods for eradication of nanobacteria
WO2000001238A1 (fr) *	1998-07-06	2000-01-13	Kajander E Olavi	Procedes relatifs a l'elimination des nanobacteries
US7250176B1 (en)	1999-04-13	2007-07-31	Beecham Pharmaceuticals (Pte) Limited	Method of treating a bacterial infection
US6294199B1 (en)	1999-04-13	2001-09-25	Beecham Pharmaceuticals (Pte) Limited	Method of treating a bacterial infection comprising administering amoxycillin
US6878386B1 (en)	1999-04-13	2005-04-12	Beecham Pharmaceuticals (Pte) Limited	Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6756057B2 (en)	2000-10-12	2004-06-29	Beecham Pharmaceuticals (Pte) Limited	Amoxicillin and potassium clavulanate dosage form
EP1330236A2 (fr)	2000-10-12	2003-07-30	Beecham Pharmaceuticals (Pte) Limited	Nouvelle formulation
US8614315B2 (en) *	2009-12-25	2013-12-24	Mahmut Bilgic	Cefdinir and cefixime formulations and uses thereof
TR201000688A2 (tr)	2010-01-29	2011-08-22	B�Lg�� Mahmut	Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar.
WO2011152809A2 (fr) *	2010-06-03	2011-12-08	Bilgic Mahmut	Formulations effervescentes comprenant de la céphalosporine et de l'acide clavulcanique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0002312B1 (fr) *	1977-11-26	1982-02-03	Beecham Group Plc	Dérivés de l'acide clavulanique et compositions pharmaceutiques les contenant
NZ198241A (en) *	1980-09-27	1983-12-16	Beecham Group Ltd	Tablet containing amoxycillin and potassium clavulanate
EP1034784A3 (fr) *	1993-01-22	2001-06-27	Smithkline Beecham Plc	Formulations pharmaceutique contenant d'acide clavulanique et un agent antibacterien

1995
- 1995-08-02 DZ DZ950107A patent/DZ1926A1/fr active
- 1995-08-21 AU AU34719/95A patent/AU3471995A/en not_active Abandoned
- 1995-08-21 WO PCT/EP1995/003322 patent/WO1996007408A1/fr not_active Ceased
- 1995-08-21 EP EP95931176A patent/EP0782443A1/fr not_active Withdrawn
- 1995-08-21 JP JP8509160A patent/JPH10505595A/ja not_active Ceased
- 1995-08-31 TR TR95/01082A patent/TR199501082A2/xx unknown
- 1995-09-01 MA MA24005A patent/MA23663A1/fr unknown
- 1995-09-01 IL IL11512595A patent/IL115125A0/xx unknown

Also Published As

Publication number	Publication date
IL115125A0 (en)	1995-12-31
EP0782443A1 (fr)	1997-07-09
WO1996007408A1 (fr)	1996-03-14
MA23663A1 (fr)	1996-04-01
TR199501082A2 (tr)	1996-06-21
AU3471995A (en)	1996-03-27
JPH10505595A (ja)	1998-06-02

Publication	Publication Date	Title
BR9610153A (pt)	1999-01-05	Formulações farmacêuticas
BR9611626A (pt)	1999-06-01	Formulações farmacéuticas
FR2705566B1 (fr)	1996-04-05	Nouvelles compositions pharmaceutiques.
NO954486D0 (no)	1995-11-08	Farmasöytiske formuleringsgrunnlag
TR199901077A3 (tr)	1999-12-21	Ispençiyari formülasyonlar.
BR9607851B1 (pt)	2009-01-13	combinaÇço e formulaÇço farmacÊutica.
DE69530325D1 (de)	2003-05-15	Aerosol-arzneiformulierungen
FI971279A0 (fi)	1997-03-26	Lääkkeitä
DE69525148D1 (de)	2002-03-14	Pharmazeutische formulierung
ID24654A (id)	2000-07-27	Formulasi farmasi omeprazola
FI973243L (fi)	1997-08-06	Uusi farmaseuttinen yhdistelmä
NO981008D0 (no)	1998-03-06	Farmasöytisk formulering
EP0850057A4 (fr)	2001-04-11	Composes pharmaceutiques
DZ1559A1 (fr)	2002-02-17	Compositions pharmaceutiques.
DZ1926A1 (fr)	2002-02-17	Formulations pharmaceutiques.
ID16781A (id)	1997-11-13	Formulasi-formulasi farmasi
ITMI941169A0 (it)	1994-06-06	Formulazioni farmaceutiche
MX9200532A (es)	1992-08-01	Agente farmaceuticos.
EP0923564A4 (fr)	1999-12-08	Composes pharmaceutiques
FI973230A0 (fi)	1997-08-05	Uusi farmaseuttinen formulaatio
MA26604A1 (fr)	2004-12-20	Compositions pharmaceutiques.
FI951155A7 (fi)	1995-09-15	Farmaseuttinen valmiste
FI923371A0 (fi)	1992-07-24	En farmaceutisk formulation.
TR199601018A1 (tr)	1997-07-21	Farmasötik bilesikler.
SE9404467D0 (sv)	1994-12-22	Drug formulations